$1.95 4.8%
Price vs. AI Score (Last 150 days)
Data gathered: December 1

Data Bits

Data Bits Value / Change Benchmark
Job Posts 1 0%
Sentiment 97 3.2%
Webpage traffic 78,000 78.4%
Employee Rating 81 0%
Linkedin Employees 318 N/A
4chan Mentions 0%
Facebook Engagement 5 -66.7%
Facebook followers 2,555 0%
Stocktwits Mentions 24 -36.8%
Stocktwits Subscribers 673 1.5%
Twitter Followers 379 0%
News Mentions 0%
Reddit Mentions 0%
Business outlook 100 0%

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

In the news

About Arcutis Biotherapeutics

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.

Arcutis Biotherapeutics
Price $1.95
Target Price Sign up
Market Cap $179M
Dividend Yield 0
Industry Biotechnology

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda
Q3 '2331M236M-205M-45M154M
Q2 '235.2M234M-229M-71M124M
Q1 '232.8M43M-47M-80M-73M
Q4 '223M40M-44M-72M-65M
Q3 '22730,00035M-40M-108M-103M

Insider Transactions

Matsuda Masaru filed to sell 46,634 shares at $2.
November 21 '23
Topper James N filed to buy 8,764,232 shares at $2.5.
October 26 '23
Burnett Patrick filed to sell 58,357 shares at $7.
August 22 '23
Matsuda Masaru filed to sell 42,146 shares at $7.8.
June 2 '23
Welgus Howard G. filed to sell 165,825 shares at $14.
April 18 '23
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2023 AltIndex. All rights reserved.